SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015762
Filing Date
2024-06-06
Accepted
2024-06-06 16:26:31
Documents
1
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 form4-06062024_080627.html 4  
1 form4-06062024_080627.xml 4 6371
  Complete submission text file 0001415889-24-015762.txt   7910
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 241025418